alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>            5
<MULTIPLIER>         1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               SEP-30-1999
<CASH>                                           4,250
<SECURITIES>                                     7,117
<RECEIVABLES>                                   13,912
<ALLOWANCES>                                      (774)
<INVENTORY>                                     28,490
<CURRENT-ASSETS>                                55,263
<PP&E>                                          94,282
<DEPRECIATION>                                 (16,860)
<TOTAL-ASSETS>                                 136,756
<CURRENT-LIABILITIES>                           11,317
<BONDS>                                          5,423
<COMMON>                                           160
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                     115,674
<TOTAL-LIABILITY-AND-EQUITY>                   136,756
<SALES>                                         68,525
<TOTAL-REVENUES>                                68,525
<CGS>                                           53,375
<TOTAL-COSTS>                                   71,853
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 540
<INCOME-PRETAX>                                 (2,824)
<INCOME-TAX>                                      (182)
<INCOME-CONTINUING>                             (2,642)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (2,642)
<EPS-BASIC>                                     (.16)
<EPS-DILUTED>                                     (.16)


</TABLE>
```

[Federal Register Volume 74, Number 94 (Monday, May 18, 2009)]
[Notices]
[Pages 23237-23238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-11535]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Surface Transportation Board

[STB Docket No. MC-F-17950]

Mayflower Transit, LCC--Pooling Agreement

AGENCY: Surface Transportation Board.

ACTION: Request for comments.

-----------------------------------------------------------------------

SUMMARY: Mayflower Transit, LLC (Mayflower), on behalf of itself and 
certain affiliated companies, filed an

[[Page 23238]]

application with the Board under 49 U.S.C. 14302 for approval of 
revisions to its pooling agreement. The Board establishes a procedural 
schedule for the submission of public comments on the proposed 
revisions, principally the requirement that carrier agents may not 
transport under their own motor carrier authority any interstate 
shipments of household goods except, subject to Mayflower policies, 
shipments for the government. After reviewing any comments received, 
the Board will determine whether it has sufficient information to 
decide whether the proposed revisions meet the standard for approval 
under section 14302 or whether a hearing is necessary prior to such a 
determination.

DATES: Comments on the proposed revisions to Mayflower's pooling 
agreement shall be filed by July 2, 2009. Mayflower may file a response 
to any comments by July 17, 2009.

ADDRESSES: An original and 10 copies of all pleadings, referring to STB 
Docket No. MC-F-17950, must be filed with the Surface Transportation 
Board, 395 E Street, SW., Washington, DC 20423-0001. In addition, one 
copy of all pleadings must be served on Mayflower's representative, 
James A. Calderwood, Zuckert, Scoutt & Rasenberger L.L.P., 888 
Seventeenth Street, NW., Washington, DC 20006-3309.

FOR FURTHER INFORMATION CONTACT: Julia Farr, (202) 245-0359. 
[Assistance for the hearing impaired is available through the Federal 
Information Relay Service (FIRS) at 1-800-877-8339.]

SUPPLEMENTARY INFORMATION: Additional information is contained in the 
Board's decision, available on our Web site at http://www.stb.dot.gov.

    Decided: May 12, 2009.

    By the Board, Acting Chairman Mulvey, and Vice Chairman 
Nottingham.
Jeffrey Herzig,
Clearance Clerk.
[FR Doc. E9-11535 Filed 5-15-09; 8:45 am]
BILLING CODE 4915-01-P
```
##### 



EXHIBIT 32

CERTIFICATION PURSUANT TO
18 U.S.C. § 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*

In connection with the Quarterly Report of IEA Income Fund VIII (the
Registrant) on Form 10-Q for the quarterly period ended September 30, 2003,
as filed with the Securities and Exchange Commission (the Report), the
undersigned, Dennis J. Tietz, the President and Chief Executive Officer of
Cronos Capital Corp., the General Partner of the Registrant, and John Kallas,
the Chief Financial Officer of Cronos Capital Corp., certify, based on their
knowledge, that:



| | (i)               |  | The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and                                 
| | ----------------- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------
|
| | (ii)              |  | The information contained in the Report fairly
presents, in all material respects, the financial condition and
results of operation of the Registrant.
|
| | November 12, 2003

| |  |    |  |                                                 
| |  | -- |  | ------------------------------------------------
| |  | By |  | /s/ Dennis J. Tietz                             
| |  |    |  |                                                 
| |  |    |  | Dennis J. Tietz, President and Chief Executive  
| |  |    |  | Officer of Cronos Capital Corp.,                
| |  |    |  | General Partner of the Registrant               
| |  |    |  |                                                 
| |  |    |  | /s/ John Kallas                                 
| |  |    |  |                                                 
| |  |    |  | John Kallas, Chief Financial Officer of Cronos  
| |  |    |  | Capital Corp., General Partner of the Registrant

A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN
PROVIDED TO THE COMPANY AND WILL BE RETAINED BY THE COMPANY AND FURNISHED TO
THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.



---

|* |  | This certification, required by Section 906 of the Sarbanes-Oxley Act of
2002, other than as required by Section 906, shall not be deemed to be
filed with the Commission or subject to the rules and regulations
promulgated by the Commission under the Securities Exchange Act of 1934,
as amended, or to the liabilities of Section 18 of said Act.
|- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   | (a)                                                   |   | the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2011 filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                  |   |                                                                                                                                                                                                                                                                                            |
|   | (b)                                                   |   | the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.                                                                                                                                  |
|   |                                                  |   |                                                                                                                                                                                                                                                                                            |   |
|   |                                                  |   |
|   | /s/ David W. Thompson                                 |   |
|   | David W. Thompson                                |   |
|   | Chairman, President and Chief Executive Officer  |   |
|   | July 29, 2011                                    |   |
|   |
<PAGE>

                                                                  EXHIBIT 31
                                                                  ----------

                                CERTIFICATION

         I, Zsolt Rumy, certify that:

         1. I have reviewed this annual report on Form 10-K of Zoltek
Companies, Inc.;

         2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this report;

         3. Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this
report;

         4. I am responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:

         (a) Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under my supervision,
to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to me by others within those
entities, particularly during the period in which this quarterly report is
being prepared;

         (b) Evaluated the effectiveness of the registrant's disclosure
controls and procedures and presented in this report my conclusions about
the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this quarterly report based on such evaluation; and

         (c) Disclosed in this report any change in the registrant's
internal control over financial reporting that occurred during the
registrant's most recent fiscal quarter that has materially affected, or is
reasonably likely to materially affect, the registrant's internal control
over financial reporting; and

         5. I have disclosed, based on my most recent evaluation of internal
control over financial reporting, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons performing the
equivalent functions):

         (a) All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record,
process, summarize and report financial information; and

         (b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal
control over financial reporting.

Date:  January 12, 2004

                               By: /s/  Zsolt Rumy
                                   -------------------------------
                                        Zsolt Rumy
                                        Chief Executive Officer
                                        Chief Financial Officer
Amendment, dated February 8, 2007 to Letter Agreement between Richard A. Aurelio



 Exhibit 10.30 
 February 8, 2007 
 Richard A. Aurelio 
 460 Indian
Springs Road 
 Jackson, Wyoming 83001 
 Dear Dick: 

This letter confirms our agreement that the letter agreement dated January 2, 2006 (the “Agreement”), between you and Varian Semiconductor Equipment
Associates, Inc. (“VSEA”) is hereby amended to extend the Term (as defined therein) until December 31, 2007. For the sake of clarity, pursuant to paragraph 4 of the Agreement, in consideration for your service as VSEA’s
Non-Executive Chairman during the period beginning January 1, 2007 and ending on December 31, 2007, VSEA shall pay you $200,000, paid periodically during this Term in the same intervals as VSEA’s payroll practices. 
 Please sign below and return a copy of this letter to confirm your agreement with the above. 
  

			
	Very Truly Yours,
	
	VARIAN SEMICONDUCTOR EQUIPMENT ASSOCIATES, INC.
		
	By:	 	 /s/ Eric Chen

	Name:	 	Eric Chen
	Title:	 	Chair, Nominating and Corporate Governance Committee


  

	
	AGREED:
	
	 /s/ Richard A. Aurelio

	Richard A. Aurelio
## Contact Information

Bethesda MD20892

helmoldhaits@nih.gov

## Media Resources

sabrina-headshot.jpg

## Summary

Dr. Helmold Hait received her Ph.D. degree in Biological Sciences/Genetics in 2014 at the Federal University of Rio de Janeiro in Brazil, where she studied polymorphisms and expression of the Alpha4 Beta7 integrin in HIV (PLWH) positive people at various stages of AIDS disease. During her postdoctoral training at the NCI's Vaccine Branch (2015-2020), she studied T cell and B cell maturation and function during HIV vaccination and infection with SHIV. During her Research Fellowship at the Vaccine Research Center/NIAID (2020-2023), she investigated the mechanism of CD4 T cell activation and the effect of broadly neutralizing antibodies against HIV in SHIV-infected Rhesus Macaques and PLWH. In 2023, she joined the NIAMS Translational Immunology Section (TIS) where she supports clinical studies by providing advice and conducting experiments involving cellular immunophenotyping and p-STAT phospho-flow assays using samples from patients with different inflammatory diseases.

## Research Statement

Currently, Dr. Helmold Hait's research focuses on the JAK/STAT signaling pathway and the characterization of immune cell dysregulation in autoimmune and inflammatory diseases using flow cytometry.

## Scientific Publications

###             Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections.        

14(1).

###             Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses.        

25(10).

###             Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.        

373(6556).

###             T(FH) Cells Induced by Vaccination and Following SIV Challenge Support Env-Specific Humoral Immunity in the Rectal-Genital Tract and Circulation of Female Rhesus Macaques.        

11().

###             An SAMT-247 Microbicide Provides Potent Protection against Intravaginal Simian Immunodeficiency Virus Infection of Rhesus Macaques, whereas an Added Vaccine Component Elicits Mixed Outcomes.        

204(12).

###             Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.        

93(4).

## Education

**Federal University of Rio De Janeiro**Ph.D., Biomedical Science/Genetics (2010-2014)

**Federal University of Rio De Janeiro**M.S., Biomedical Science/Genetics (2009-2010)

**UNIRIO**B.S., Biomedicine (2005-2008)

 

## Experience

**Research Fellowship**Vaccine Research Center/NIAID/NIH (2020-2023)

**Postdoctoral Fellowship**National Cancer Institute/NIH (2015-2020)

November 2023

Back to Top
#### Bigelow *against*Johnson.

in an action on the- 7th section of the act *to -Jay. ■a duly on strong liquors,*(! *R. L.*178.) where the offence charged in the declaration is the selling ofstrong or spirituous liquors without «.license, contrary *to the*first clause in 'that section of the statute, the plaintiff cannot proceed for the offence specified in the. subsequent clause, viz. selling liquors to be drank ill the house Of the seller, witboutenteringjnto a.recognisance..

Where a penal statute- gives no form of declaring, the -plaintiff must .set forth specially the facta which cobstitute the offence. '' , . . •

IN ERROR, on *certiorari*to a justice’s court.

*Johnson,*the defendant in- error., brbught ah action of debt in *429the court below, against the plaintiff in error, and declared generally for the penalty of twenty-five dollars for selling strong 'and spirituous liquors, contrary to the 7th section of the act to lay a duty on strong liquors, &c. The plaintiff being called upon for the particulars of his charge, specified certain small quantities of liquors sold to particular persons: the defendant then pleaded the general issue, and at the trial the plaintiff proved his specific charges, and, also, that the liquor so purchased was immediately drank by the purchasers in the defendant’s store. The defendant produced in evidence, and relied upon it as his defence, a regular license from the commissioners .of excise, permitting him to retail spirituous liquors under five gallons. The justice overruled this defence, and gave judgment for the plaintiff below for the penalty demanded, with costs. •

*Per Curiam,.*

The 7th section of the act provides, “ that if any person shall sell by retail any strong or spirituous liquors, without having a license, or if any person shall sell any strong or spirituous liquors; to be drank in his or her house, outhouse, yard, or garden, without having entered into a recognisance, every person who shall be guilty of either of the offences aforesaid, shall, for each offence, forfeit the sum of twenty-five dollars.” Here are two distinct offences described, viz. one of selling by-retail without license, and the other, selling liquor to be drank in the house, &c. without recognisance.

It is a well-settled rule, that in declaring for offences against penal statutes, (where no form is expressly given,) the plaintiff is bound to set forth specially the facts on which he relies to constitute the offence. No form is prescribed by the statute in this case ; and the plaintiff here declared against the defendant for selling spirituous liquors by retail to *A.*and *B.,*contrary to the 7th section of the act. This declaration does not embrace the offence of selling liquors to be drank in the house, &c, without recognisance ; or, at least, it is equivocal. The defendant was not apprized that the latter offence would be charged against him; and as to the first offence his license was a complete answer.

Judgment reversed.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Homeland Security

###### Federal Emergency Management Agency

          - [Internal Agency Docket No. FEMA-1832-DR; Docket ID FEMA-2008-0018]

# AGENCY:

Federal Emergency Management Agency, DHS.

# ACTION:

Notice.

# SUMMARY:

This notice amends the notice of a major disaster declaration for the State of Indiana (FEMA-1832-DR), dated April 22, 2009, and related determinations.

# DATES:

Effective Date: May 13, 2009.

# FOR FURTHER INFORMATION CONTACT:

Peggy Miller, Disaster Assistance Directorate, Federal Emergency Management Agency, 500 C Street, SW., Washington, DC 20472, (202) 646-3886.

# SUPPLEMENTARY INFORMATION:

The notice of a major disaster declaration for the State of Indiana is hereby amended to include the following areas among those areas determined to have been adversely affected by the event declared a major disaster by the President in his declaration of April 22, 2009.

Daviess, Lawrence, and St. Joseph Counties for Individual Assistance.

(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster Legal Services; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048, Disaster Housing Assistance to Individuals and Households in Presidentially Declared Disaster Areas; 97.049, Presidentially Declared Disaster Assistance—Disaster Housing Operations for Individuals and Households; 97.050 Presidentially Declared Disaster Assistance to Individuals and Households—Other Needs; 97.036, Disaster Grants—Public Assistance (Presidentially Declared Disasters); 97.039, Hazard Mitigation Grant.)

Nancy Ward,

Acting Administrator, Federal Emergency Management Agency.

[FR Doc. E9-12158 Filed 5-22-09; 8:45 am]

BILLING CODE 9111-23-P